Johnson & Johnson - Index

Johnson & Johnson - report - Index

Medical Devices & Diagnostics Segment Sales
ORTHO-CLINICAL
DIAGNOSTICS®*
$1.7
+11%
VISION CARE
$2.2
+18%
*Includes Therakos, Inc.
CORDIS®
$3.4
(16%)
LIFESCAN®
$2.4
+14%
Ethicon Endo-Surgery Delivers
Growth in 2007
In 2007, Ethicon Endo-Surgery,
Inc. continued to deliver innovative
solutions for minimally invasive and open
surgical procedures that help transform
patient care. With the U.S. FDA approval
of the REALIZE ™ Adjustable Gastric Band
for weight loss in morbidly obese patients, Ethicon
Endo-Surgery became the world’s only company with a
complete portfolio of offerings for the surgical treatment
of morbid obesity. These treatments—commonly referred
to as gastric banding and gastric bypass surgery—can
help patients lose weight and improve health conditions
related to morbid obesity, such as Type 2 diabetes and
cardiovascular disease. (See related story on page 10.)
Ethicon Endo-Surgery added to its growing portfolio
of HARMONIC ® technology with the launch of HARMONIC
FOCUS ™ Curved Shears for use in thyroid surgery and other
neck or lymph node procedures involving delicate tissue.
HARMONIC ® devices enable surgeons to perform precise
cutting and to control bleeding, resulting in minimal
damage to a patient’s surrounding tissue.
The company also launched the ENDOPATH ®
DEXTRUS ™ Access System. This technology platform
includes a new hand access port and first-to-market
finger-mounted instruments that provide surgeons with
unique access to hard-to-reach operative spaces.
Sales by Major Franchise
2007 Sales: $21.7 billion Growth Rate: 7.2%
(in billions of dollars)
ETHICON
ENDO-SURGERY®
$3.8
+14%
DEPUY®
$4.6
+12%
ETHICON®
$3.6
+12%
Twenty Years of
Providing Clearer
Vision
In 2007, Johnson & Johnson Vision Care, Inc.
continued its 20-year heritage of innovation
in providing contact lens wearers with
improvements in comfort, convenience
and UV protection. The U.S. launch of
1-DAY ACUVUE ® MOIST ™ Brand Contact
Lenses marked a significant new product
introduction. The daily disposable lenses
feature LACREON ™ technology, which locks
in moisture and may improve comfort for
those who experience discomfort and itching
associated with allergies during contact
lens wear.
New product launches also included
ACUVUE ® OASYS ™ with HYDRACLEAR ™ Plus
and ACUVUE ® ADVANCE ™ Brand Contact
Lenses in Japan. Other contributors to
success in 2007 included 1-DAY ACUVUE ®
DEFINE ™ Brand Contact Lenses in Asia
Pacific and Japan, and ACUVUE ® ADVANCE ™
for Astigmatism in the U.S.
The Vision Care franchise recorded
$2.2 billion in sales, making it the largest
contact lens business in the world.
New Products
From ETHICON
Advance
Healing
Thrombin, a protein
that promotes clotting,
is used in a range of
surgical procedures to help
control bleeding. In 2007,
ETHICON, Inc. launched
EVITHROM ™ Thrombin
Topical (Human),
a manufactured human
plasma–derived product
that is the first alternative
to thrombin from cattlederived
proteins.
In early 2008, ETHICON
also received an expanded
indication to market
EVICEL ® Fibrin Sealant
(Human) for use in all
surgical procedures. An
advanced product, EVICEL ®
is used to control bleeding
when standard surgical
techniques are ineffective
or impractical. Both
products were developed in
collaboration with OMRIX
Biopharmaceuticals.
A new product available
in Europe, the PRINEO ®
Skin Closure System,
offers a faster alternative
to traditional suturing and
stapling of surgical incisions.
PRINEO ® combines the
company’s proprietary
PROLENE ® Polypropylene
Mesh and an adhesive to
close the incision.
Y E A R I N R E V I E W 29